🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

Laboratorios Liconsa S.A. — Licensed Medicines

17 medicines held by Laboratorios Liconsa S.A. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 17 products held by Laboratorios Liconsa S.A.
MedicineActive substanceLicence holderStatus
Atorvastatin Liconsa 10 mg film-coated tablets
PA1239/028/001
Atorvastatin calcium trihydrate Laboratorios Liconsa S.A. Not marketed
Atorvastatin Liconsa 20 mg film-coated tablets
PA1239/028/002
Atorvastatin calcium trihydrate Laboratorios Liconsa S.A. Not marketed
Atorvastatin Liconsa 40 mg film-coated tablets
PA1239/028/003
Atorvastatin calcium trihydrate Laboratorios Liconsa S.A. Not marketed
Atorvastatin Liconsa 80 mg film-coated tablets
PA1239/028/004
Atorvastatin calcium trihydrate Laboratorios Liconsa S.A. Not marketed
Formoterol 12 micrograms inhalation powder, hard capsule
PA1239/001/001
Formoterol fumarate Laboratorios LICONSA, S.A. Not marketed
Mirpresoc 20 mg Tablets
PA1239/017/001
Telmisartan Laboratorios Liconsa S.A. Not marketed
Mirpresoc 40 mg Tablets
PA1239/017/002
Telmisartan Laboratorios Liconsa S.A. Not marketed
Mirpresoc 80 mg Tablets
PA1239/017/003
Telmisartan Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 100 mg prolonged-release tablets
PA1239/029/003
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 150 mg prolonged-release tablets
PA1239/029/004
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 200 mg prolonged-release tablets
PA1239/029/005
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 25 mg prolonged-release tablets
PA1239/029/001
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 250 mg prolonged-release tablets
PA1239/029/006
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 50 mg prolonged-release tablets
PA1239/029/002
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 40 mg/12.5 mg tablets
PA1239/025/001
Telmisartan, Hydrochlorothiazide Laboratorios Liconsa S.A. Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 80 mg/12.5 mg tablets
PA1239/025/002
Telmisartan, Hydrochlorothiazide Laboratorios Liconsa S.A. Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 80 mg/25 mg tablets
PA1239/025/003
Telmisartan, Hydrochlorothiazide Laboratorios Liconsa S.A. Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 20 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.